7302
A. Ogata et al. / Bioorg. Med. Chem. Lett. 20 (2010) 7299–7302
miR-199a-3p strands by using the DANap-modified miR-199a-5p/
miR-199a-3p duplex. Thus, DANap modification would be useful
to identify endogenous mRNA targets for other miRNAs.
Acknowledgments
This study was supported in part by a Grant-in-Aid from Precur-
sory Research for Embryonic Science and Technology (PRESTO) of
Japan Science and Technology (JST) and a Grant-in-Aid for Scien-
tific Research (C) from Japan Society for the Promotion of Science
(JSPS) to Y.U., and a Grant-in-Aid for Scientific Research on Priority
Areas from the Ministry of Education, Culture, Sports, Science, and
Technology (MEXT) of Japan (17016015) to H.I. We are also grate-
ful to Dr. Y. Kitamura (Gifu University) for providing technical
assistance.
Figure 5. Detection of target proteins by high-level expression of miR-199a-5p and
miR-199a-3p. MDA-MB-435 cells were transfected with 30 nM DANap-modified
miRNA duplexes, and after 48 h, protein extracts were prepared. IKKb, fibronectin,
and b-actin proteins were analyzed by western blotting.
Supplementary data
using the same luciferase assay system (Fig. 4). For DANap-modi-
fied duplexes, miRNA6 modified at the 50-terminus of the miR-
199a-5p strand reduced luciferase activity of psi-199a-3p from
18% to 5%, but not of psi-199a-5p. In contrast, miRNA7 modified
at the 50-terminus of the miR-199a-3p strand reduced luciferase
activity of psi-199a-5p from 38% to 9%, but not of psi-199a-3p. It
is noteworthy that the 5p and 3p strands of miRNA6 and miRNA7
did not suppress luciferase activity efficiently due to the applied
mutations, and the anticipated effects of the synthesized duplexes
were enhanced as compared to duplexes with the natural miRNA
sequence, thus resulting in better strand selectivity.
It was previously reported that IKKb is a target of miR-199a-5p
and fibronectin, a target of miR-199a-3p.16,17 Therefore, we tried to
determine endogenous miR-199a target genes by using the strand-
specific over-expression method that we devised. MDA-MB-435
cells (expressing low levels of miR-199a) were transfected with
DANap-modified miR-199a duplexes for over-expression. Western
blotting showed that in MDA-MB-435 cells, IKKb expression was
suppressed by selective expression of miR-199a-5p originating
from miRNA7 duplexes, and not miRNA6 (Fig. 5). It was also shown
that fibronectin expression was specifically suppressed by miR-
NA6, and not miRNA7. Our method involving selective over-
expression of miR-199a-5p and miR-199a-3p could be used for
the regulation of endogenous target gene expression and that it
could be applied for the identification of new target genes.
Supplementary data associated with this article can be found, in
References and notes
1. Winter, J.; Jung, S.; Keller, S.; Gregory, R. I.; Diederichs, S. Nat. Cell Biol. 2009, 11,
228.
2. Tang, G. Trends Biochem. Sci. 2005, 30, 106.
3. Esquela-Kerscher, A.; Slack, F. J. Nat. Rev. Cancer 2006, 6, 259.
4. Murakami, Y.; Yasuda, T.; Saigo, K.; Urashima, T.; Toyoda, H.; Okanoue, T.;
Shimotohno, K. Oncogene 2006, 25, 2537.
5. Iorio, M. V.; Visone, R.; Di Leva, G.; Donati, V.; Petrocca, F.; Casalini, P.; Taccioli,
C.; Volinia, S.; Liu, C.-G.; Alder, H.; Calin, G. A.; Ménard, S.; Croce, C. M. Cancer
Res. 2007, 67, 8699.
6. Lee, J.-W.; Choi, C. H.; Choi, J.-J.; Park, Y.-A.; Kim, S.-J.; Hwang, S. Y.; Kim, W. Y.;
Kim, T.-J.; Lee, J.-H.; Kim, B.-G.; Bae, D.-S. Clin. Cancer Res. 2008, 14, 2535.
7. Watanabe, T.; Sato, T.; Amano, T.; Kawamura, Y.; Kawamura, N.; Kawaguchi, H.;
Yamashita, N.; Kurihara, H.; Nakaoka, T. Dev. Dyn. 2008, 237, 3738.
8. Murakami, Y.; Aly, H. H.; Tajima, A.; Inoue, I.; Shimotohno, K. J. Hepatol. 2009,
50, 453.
9. Schwarz, D. S.; Hutvagner, G.; Du, T.; Xu, Z.; Aronin, N.; Zamore, P. D. Cell 2003,
115, 199.
10. Khvorova, A.; Reynolds, A.; Jayasena, S. D. Cell 2003, 115, 209.
11. Ro, S.; Park, C.; Young, D.; Sanders, K. M.; Yan, W. Nucleic Acids Res. 2007, 35,
5944.
12. Griffiths-Jones, S. Methods Mol. Biol. 2006, 342, 129.
13. Chen, P. Y.; Weinmann, L.; Gaidatzis, D.; Pei, Y.; Zavolan, M.; Tuschl, T.; Meister,
G. RNA 2008, 14, 263.
14. Ueno, Y.; Watanabe, Y.; Shibata, A.; Yoshikawa, K.; Takano, T.; Kohara, M.;
Kitade, Y. Bioorg. Med. Chem. 2009, 17, 1974.
15. Yoshikawa, K.; Ogata, A.; Matsuda, C.; Kohara, M.; Iba, H.; Kitade, Y.; Ueno, Y.
Bioconjugate Chem., submitted for publication.
16. Chen, R.; Alvero, A. B.; Silasi, D. A.; Kelly, M. G.; Fest, S.; Visintin, I.; Leiser, A.;
Schwartz, P. E.; Rutherford, T.; Mor, G. Oncogene 2008, 27, 4712.
17. Lee, D. Y.; Shatseva, T.; Jeyapalan, Z.; Du, W. W.; Deng, Z.; Yang, B. B. PLoS One
2009, 4, e4527.
In conclusion, we have demonstrated the synthesis of miRNA du-
plexes modified with biaryl compounds. We found that the DANap
modification was the most effective in eliciting strand specificity
of miR-199a-5p/miR-199a-3p duplexes. Further, we succeeded in
identifying endogenous mRNA targets for miR-199a-5p and